Pharma

Rx Rundown: Novo Nordisk, Servier, Novartis and more

Check out this week’s medical marketing news, dealmaking and industry chatter.

Heerea Rikhraj

September 11, 2025

4:32 pm

美女免费一级视频在线观看

Deals:

Novartis is set to acquire Tourmaline Bio for $1.4 billion.

Servier buys Medicxi startup’s fragile X candidate for up to $450 million.

Sandoz and Regeneron reached an agreement, resolving all patent litigation related to its U.S. aflibercept biosimilar.

Vitality announced a new GPO agreement with the Health Plan Alliance.

Cliniphai and Gibson Research Consultancy announced a partnership.

FDA:

The FDA launched a green list to protect Americans from illegally imported GLP-1 drug ingredients.

The agency cleared eGenesis to launch the first U.S. clinical trial of gene-edited pig kidneys for patients with end-stage kidney disease.

The FDA approved an expanded indication for Takeda’s Vonvendi [von Willebrand factor (Recombinant)] for adults and children with von Willebrand disease.

Ionis Pharmaceuticals received a Breakthrough Therapy designation for ION582 in Angelman syndrome.

PMV is set to pursue FDA approval in ovarian cancer.

Johnson & Johnson received FDA approval of Inlexzo (gemcitabine intravesical system) for certain bladder cancers.

The FDA issued a new guidance to expand non-opioid options for chronic pain.

Indian drugmaker Sun Pharmaceutical Industries said the FDA determined its Halol plant in Gujarat was not compliant with the regulator’s manufacturing rules.

Funding rounds:

Henry Schein announced a $750 million share repurchase plan.

LB Pharma raises $285 million in Nasdaq debut.

Odyssey Therapeutics raised a $213 million Series D funding round.

CAMP4 Therapeutics announced an oversubscribed private placement of up to $100 million.

YolTech Therapeutics raised a $44.5 million Series B funding round.

Silexion Therapeutics priced a $6 million public offering.

Layoffs:

Novo Nordisk is cutting some 9,000 staff across its global operations in a bid to generate around $1.25 billion in annualized savings through 2026.

Merck is scrapping its $1.3 billion plans in the U.K. and laying off 125 employees there.

Industry news:

Eli Lilly launched TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment.

Dianthus Therapeutics said its experimental treatment for myasthenia gravis achieved the primary goals of a Phase 2 study.

Pfizer and BioNTech reported top-line Phase 3 study results showing their COVID-19 vaccine Comirnaty elicited an immune response against the most prevalent circulating strain of the SARS-Cov-2 virus.

Rapport Therapeutics posted topline mid-stage data indicating that its epilepsy pill can cut seizure frequency.

IPG Health expanded its Influencer ID marketing program into Europe.

Alkermes reported promising results for an experimental narcolepsy drug.

Lilly’s blood drug Jaypirca helped delay progression of certain lymphomas in a late stage trial.

Johnson & Johnson said its Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer.

AstraZeneca said its Tagrisso plus chemotherapy demonstrated a median overall survival of nearly four years in a global Phase III trial for EGFR-mutated advanced lung cancer.

Within3 Insights unveiled its Launch Intelligence and Know Everything solutions.

Havas Health Network expanded into Taiwan.

Amgen and Kyowa Kirin reported positive rocatinlimab results in an eczema trial.

The World Health Organization declared an end of global emergency over mpox outbreak.

The American Academy of Family Physicians recommended that all adults over 18, as well as children and pregnant women, get COVID vaccines.

Regeneron said Libtayo (cemiplimab) plus chemotherapy results at five years reinforce significant and durable improvements in survival outcomes for advanced non-small cell lung cancer.

Doceree launched RepTwin.

Legendairy Milk dropped Bloat Baddie, its newest 3-in-1 daily digestive capsule.
Eversana was named U.S. commercialization partner for Precigen’s launch of Papzimeos.

To read last week’s edition of Rx Rundown, click here.

From Our Partners

Partner Content

Places to Be 2024

Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

Partner Content

Turning nudges into big wins in point-of-care marketing

How artificial intelligence can deliver more meaningful business outcomes for marketers.

Partner Content

For pharma brands, streaming is critical for awareness

By leveling up their streaming campaigns, advertisers can achieve big lifts in awareness and sales of their medications among all demographics.

Partner Content

HCG: Accelerating the impact of your science

In a world where healthcare is moving fast, HCG is moving faster. Always ahead of the curve, HCG is spearheading the charge to turn scientific potential into real-world impact.

The song grew faint and louder again, then ceased, and she took her hand off his arm. "By-and-by the Tartars did come in reality, and the signal was sent out again. But this time no army came, nor did a single general turn his face to Pekin. The city fell into the hands of the invaders, and they are there to-day. So much for what a woman did; but it sounds too much like the story of 'The Boy and the Wolf' to be true. I stood equally amazed and alert. The voices still growled in the next room, and my horse's bridle still hung before the window. I peered out; there stood the priceless beast. I came a sly step nearer, and lo! in his shadow, flattened against the house, face outward, was Coralie Rothvelt comically holding the forked stick at a present-arms. Throbbing with a grateful, craving allegiance, I seized the rein. Then I bent low out the window and with my free hand touched her face as it turned upward into a beam of moonlight. She pressed my fingers to her lips, and then let me draw her hand as far as it could come and cover it with kisses. Then she drew me down and whispered "You'll do what I've asked?" His lodgings were situated at the lower end of the town. The accommodation consisted[Pg 64] of a small bedroom, which he shared with a fellow clerk, and a place at table with the other inmates of the house. The street was very dirty, and Mrs. Flack's house alone presented some sign of decency and respectability. It was a two-storied red brick cottage. There was no front garden, and you entered directly into a living room through a door, upon which a brass plate was fixed that bore the following announcement:— "Meanwhile the clouds were gathering around you. Prout finds your husband's brother by a happy chance. Once he has done this, things become easy for us. The more easy they become for us the more desperate they grow for you. Then you decide that you must recover those notes from Isidore. You take out your motor car, so cunningly disguised in blacklead----" it makes the fourth time. No doubt about it, Daddy, goods are not High in the air, in the first mausoleum, at the head and foot of the white marble cenotaph, covered with letters that look like creepers, are tablets bearing inscriptions which record the life of the hero; and above the sarcophagus rises an almost impossibly light and airy structure—a canopy of white marble supported on columns as slender as flower-stems. And the Indian may be trusted to know of these. Here where the jacales clustered, there was grass and wood and water that might last indefinitely. The fortifications of Nature had been added to those of Nature's man. It was a stronghold. "Certainly," said the Surgeon, stopping on his way. "I guess I can spare a minute. Take off that bandage, my boy." MRS. GORDON: Not those poor things. They're slaves. He left the post with a great oath in his heart, and a thin trickle of blood on his chin. That summer old Mrs. Backfield became completely bedridden. The gratefulness of sunshine to her old bones was counteracted by the clammy fogs that streamed up every night round the farm. It was an exceptionally wet and misty summer—a great deal of Reuben's wheat rotted in the ground, and he scarcely took any notice when Tilly announced one morning that grandmother was too ill to come downstairs. Merritt presently departed; and at eight the two confederates again met. Soon a compact and resolute body of more than twenty men slowly and cautiously proceeded to the castle, and, in double file, ensconced themselves close to the walls, and so contiguous to the gate of usual egress as to be ready to rush in at the first opening. They had stood thus, scarcely drawing breath, for about half an hour; and Merritt, who, with the smith, was at the head of the little band, was about to propose that they should attempt to force an entrance, when the gate opened, and John Byles, who had been engaged upon some business with Calverley, unsuspectingly issued forth. HoME 美女免费一级视频在线观看 ENTER NUMBET 0018anima.org.cn
s4x2rcbu.com.cn
www.sdyufeng.com.cn
meihao365.net.cn
www.666books.com.cn
www.dianhon.com.cn
www.leahy.com.cn
www.intnet.net.cn
www.nepci.com.cn
www.hy-qd.com.cn

美女免费一级视频在线观看

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Rx Rundown: Novo Nordisk, Servier, Novartis and more

美女免费一级视频在线观看

Deals:

FDA:

Funding rounds:

Layoffs:

Industry news:

MM+M Media Summit 2025

From Our Partners

Partner Content

Places to Be 2024

Partner Content

Turning nudges into big wins in point-of-care marketing

Partner Content

For pharma brands, streaming is critical for awareness

Partner Content

HCG: Accelerating the impact of your science

美女免费一级视频在线观看

Quick Links

美女免费一级视频在线观看

Deals:

FDA:

Funding rounds:

Layoffs:

Industry news:

Related Articles

MM+M Media Summit 2025

From Our Partners

Partner Content

Places to Be 2024

Partner Content

Turning nudges into big wins in point-of-care marketing

Partner Content

For pharma brands, streaming is critical for awareness

Partner Content

HCG: Accelerating the impact of your science